Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT06701617
Recruiting Not applicable

In-person and Telehealth Visual Rehabilitation for Children With Low Vision

NCT06701617 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2024-11-25
Last updated
2026-08-14

Condition(s) studied

Visual RehabilitationOddball DesignCerebral Visual ImpairmentPassive Visual StimulationPerceptual Learning

Investigational drug(s) / intervention(s)

restorative visual rehabitation

restorative visual rehabitation: black-and-white checkerboard patterns, visual stimulation program, restorative visual rehabitation

Study summary

Restorative visual rehabilitation is frequently used to enhance the visual development and function of children with low vision. An important strategy within this field is visual stimulation, which is particularly used for infants and toddlers with low vision, as well as for children who have both developmental disabilities and low vision.This study has two primary objectives.The first objective is to examine the effect of using intensive, specific, and flickering black-and-white checkerboard patterns to enhance visual function in children with mild to moderate low vision. The second objective is to develop a visual stimulation program tailored for children with severe or profound multiple disabilities and visual impairments, and to evaluate its effectiveness. For both objectives, the visual stimulation intervention will be provided through either in-person or remote delivery

Eligibility

Sex
ALL
Min age
1 Month
Max age
18 Years
Healthy volunteers
No
Passive visual stimulation group Inclusion Criteria: 1. Children aged less than or equal to 18 years old. 2. The causes of visual disorder in children are unlimited. 3. The acuity of the children's better eye was ≤ 0.2. 4. Children with multiple disabilities and visual disorders typically exhibit developmental levels ranging from moderate to severe or below. 5. The parents of these children exhibit a positive attitude and are willing to cooperate with visual learning programs. 6. Infants under 1 year old with low vision without other developmental issues , under or equal to moderate developmental issues. Exclusion Criteria: 1. Significant refractive errors that affect acuity but are unable to cooperate with wearing corrective glasses in two training sessions. 2. Requires patching for monocular vision rehabilitation but is unable to cooperate with patching in two training sessions. 3. The individual is unable to adapt to the training environment and cooperate with visual learning in two sessions due to unstable emotions or difficulty adapting to the environment. Perceptual learning group Inclusion Criteria (1)Children aged less than or equal to 12 years old. (2)No restrictions on the causes of visual impairment in children. (3)The acuity of the children's better eye was ≤ 0.5 (4)If children have additional developmental issues, their disability severity should primarily be mild or moderate. (5)The primary caregiver demonstrates a positive attitude and is willing to cooperate with the visual training program. (6)The child is capable of completing calibration with an eye-tracking device. Exclusion Criteria 1. Significant refractive errors that severely affect vision, where the child cannot adapt to wearing corrective glasses within two training sessions. 2. Requires occlusion therapy for monocular visual rehabilitation but cannot cooperate with occlusion within two training sessions. 3. Inability to adapt to the training environment or cooperate with visual training due to emotional instability or difficulty adjusting within two training sessions. 4. Unstable physiological conditions (e.g., epilepsy, sleep disturbances) that prevent consistent participation in visual training.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Occupational Therapy, College of Medicine, National Taiwan University Taipei Taiwan Recruiting

More National Taiwan University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06701617 on ClinicalTrials.gov ↗ ← All trials in Taiwan